Common use of Attorney-Client Privilege Clause in Contracts

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges.

Appears in 11 contracts

Samples: License and Collaboration Agreement (Pandion Therapeutics Holdco LLC), License and Collaboration Agreement (Pandion Therapeutics Holdco LLC), License and Collaboration Agreement (Pandion Therapeutics Holdco LLC)

AutoNDA by SimpleDocs

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (ai) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (bii) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (ciii) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (div) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 6 contracts

Samples: Collaboration Agreement, Collaboration Agreement (Amgen Inc), Collaboration Agreement (BeiGene, Ltd.)

Attorney-Client Privilege. Neither Party is waiving, nor shall will be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall will have the right to assert such protections and privileges.

Appears in 6 contracts

Samples: Exclusive License Agreement (CM Life Sciences III Inc.), Strategic Collaboration and License Agreement (CM Life Sciences III Inc.), Exclusive License Agreement (CM Life Sciences III Inc.)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Original Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 4 contracts

Samples: Option, License, and Collaboration Agreement, Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC), Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 4 contracts

Samples: License Agreement (Ikena Oncology, Inc.), Collaboration and License Agreement (Array Biopharma Inc), Supply Agreement (Amgen Inc)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving other Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 4 contracts

Samples: License Agreement (Erasca, Inc.), License Agreement (Erasca, Inc.), License and Collaboration Agreement (ADC Therapeutics SA)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (ai) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (bii) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (ciii) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (div) intend that after the Effective Date [*] both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 2 contracts

Samples: License Agreement (Amgen Inc), License Agreement (Amgen Inc)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information Agreement (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Execution Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges.

Appears in 2 contracts

Samples: License and Collaboration Agreement, License and Collaboration Agreement (Protagonist Therapeutics, Inc)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like like, as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving other Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date Date, both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 2 contracts

Samples: License and Collaboration Agreement (Graphite Bio, Inc.), License and Collaboration Agreement (Oyster Point Pharma, Inc.)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 2 contracts

Samples: Collaboration Agreement (BioNTech SE), Collaboration Agreement (BioNTech SE)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Execution Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges. Notwithstanding the foregoing, nothing in this Section 9.7 shall apply with respect to a dispute between the Parties (including their respective Affiliates).

Appears in 2 contracts

Samples: License and Collaboration Agreement (DiaMedica Therapeutics Inc.), License and Collaboration Agreement (DiaMedica Therapeutics Inc.)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed.

Appears in 2 contracts

Samples: Fast Skeletal Regulatory Activator Agreement (Cytokinetics Inc), License and Collaboration Agreement (Cytokinetics Inc)

Attorney-Client Privilege. Neither The Disclosing Party is not waiving, nor shall and will not be deemed to have waived or diminished, any of its attorney work work-product protections, attorney-client privileges privileges, or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: Parties (a) share a common legal and commercial interest in such disclosure all of the Disclosing Party’s Confidential Information that is subject to such privileges and protections; (b) are or may become joint defendants in legal proceedings to which the information Disclosing Party’s Confidential Information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party any party become subject to any actual or threatened legal proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges.and

Appears in 2 contracts

Samples: Academic and Clinical Collaboration Agreement, Industry Sponsored Research and Clinical Collaboration Agreement

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges. Notwithstanding the foregoing, nothing in this Section 10.7 shall apply with respect to a dispute between the Parties (including their respective Affiliates).

Appears in 2 contracts

Samples: License and Collaboration Agreement (Zai Lab LTD), License and Collaboration Agreement (Five Prime Therapeutics Inc)

Attorney-Client Privilege. Neither No Party is waiving, nor shall will be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: : (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; ; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; ; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall will have the right to assert such protections and privileges.

Appears in 2 contracts

Samples: Exclusive License and Commercialization Agreement (Therapeutics Acquisition Corp.), Exclusive License and Commercialization Agreement (Therapeutics Acquisition Corp.)

Attorney-Client Privilege. Neither The Disclosing Party is not waiving, nor shall and will not be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: parties (a) share a common legal and commercial interest in such disclosure all of the Disclosing Party’s Confidential Information that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings Proceedings to which the information Disclosing Party’s Confidential Information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party party become subject to any actual or threatened proceeding Proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges.the

Appears in 2 contracts

Samples: Asset Purchase Agreement (Portola Pharmaceuticals Inc), Asset Purchase Agreement (Portola Pharmaceuticals Inc)

Attorney-Client Privilege. Neither Party is waiving, nor shall will be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall will have the right to assert such protections and privileges. [***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.

Appears in 2 contracts

Samples: Joint Venture Agreement (CRISPR Therapeutics AG), Joint Venture Agreement (CRISPR Therapeutics AG)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving other Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: : (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 1 contract

Samples: License and Collaboration Agreement (Instil Bio, Inc.)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information Agreement (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s 's Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Original Execution Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges.. ​ ​

Appears in 1 contract

Samples: License and Collaboration Agreement (Protagonist Therapeutics, Inc)

Attorney-Client Privilege. Neither Party is waiving, nor shall will be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving Party and the Disclosing Party shall will have the right to assert such protections and privileges. Notwithstanding the foregoing, nothing in this Section 7.4 will apply with respect to a Dispute between the Parties (including their respective Affiliates).

Appears in 1 contract

Samples: License Agreement (Blueprint Medicines Corp)

AutoNDA by SimpleDocs

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges. Notwithstanding the foregoing, nothing in this Section 12.7 shall apply with respect to a dispute between the Parties (including their respective Affiliates).

Appears in 1 contract

Samples: Collaboration Agreement (Arvinas, Inc.)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (ai) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (bii) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (ciii) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (div) intend that after the Original Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 1 contract

Samples: Collaboration Agreement (Amgen Inc)

Attorney-Client Privilege. Neither The Disclosing Party is not waiving, nor shall and will not be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges privileges, or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: parties (a) share a common legal and commercial interest in such disclosure all of the Disclosing Party’s Confidential Information that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings Proceedings to which the information Disclosing Party’s Confidential Information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party party become subject to any actual or threatened proceeding Proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both Closing, the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges.

Appears in 1 contract

Samples: Asset Purchase Agreement (Chad Therapeutics Inc)

Attorney-Client Privilege. Neither Party is waiving, nor shall will be deemed to have waived or diminished, any of its attorney work product protections, attorney-client attorney‑client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall will have the right to assert such protections and privileges.

Appears in 1 contract

Samples: Exclusive License Agreement (Eagle Pharmaceuticals, Inc.)

Attorney-Client Privilege. Neither Party is waiving, nor shall will be deemed to have waived or diminished, any of its attorney work product protections, attorney-attorney client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall will have the right to assert such protections and privileges.

Appears in 1 contract

Samples: Joint Venture Agreement (CRISPR Therapeutics AG)

Attorney-Client Privilege. Neither Party is waiving, nor shall will be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall will have the right to assert such protections and privileges.

Appears in 1 contract

Samples: Collaboration Agreement and License Option (Capricor Therapeutics, Inc.)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 1 contract

Samples: Collaboration and Option Agreement (Cytokinetics Inc)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Confidential EXECUTION VERSION Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Execution Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges. Notwithstanding the foregoing, nothing in this Section 9.8 shall apply with respect to a dispute between the Parties (including their respective Affiliates).

Appears in 1 contract

Samples: License and Collaboration Agreement (Five Prime Therapeutics Inc)

Attorney-Client Privilege. Neither Party is waiving, nor shall will be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date [***] both the Receiving receiving Party and the Disclosing disclosing Party shall will have the right to assert such protections and privileges.

Appears in 1 contract

Samples: Collaboration, Option and License Agreement (Exicure, Inc.)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving receiving Party, regardless of whether the Disclosing disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (ai) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; , (bii) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; , (ciii) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing disclosing Party’s Confidential Information covered by such protections and privileges relates; , and (div) intend that after the Effective Date both the Receiving receiving Party and the Disclosing disclosing Party shall have the right to assert such protections and privileges.

Appears in 1 contract

Samples: License and Collaboration Agreement (Amgen Inc)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Date both the Receiving Party and the Disclosing Party shall have the right to may assert such protections and privileges. Notwithstanding the foregoing, nothing in this Section 11.7 shall apply with respect to a dispute between the Parties (including their respective Affiliates).

Appears in 1 contract

Samples: Collaboration, Option, and License Agreement (Vir Biotechnology, Inc.)

Attorney-Client Privilege. Neither Party is waiving, nor shall be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges or the like as a result of disclosing information pursuant to this Agreement, or any of its Confidential Information (including Confidential Information related to pending or threatened litigation) to the Receiving Party, regardless of whether the Disclosing Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties: (a) share a common legal and commercial interest in such disclosure that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which the information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should either Party become subject to any actual or threatened proceeding to which the Disclosing Party’s Confidential Information covered by such protections and privileges relates; and (d) intend that after the Effective Execution Date both the Receiving Party and the Disclosing Party shall have the right to assert such protections and privileges.

Appears in 1 contract

Samples: License and Collaboration Agreement (Newlink Genetics Corp)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!